We also assessed the protein changes of KYAT1 by western blot and immunohistochemistry, which revealed significantly decreased KYAT1 in AD brains (p = 4.2 × 10−3, Figs. 7c,d). This evidence concerns the gene KYAT1 and Alzheimer disease.